MedPath
HSA Approval

GENEXOL INJECTION 6 mg/ml

SIN12050P

GENEXOL INJECTION 6 mg/ml

GENEXOL INJECTION 6 mg/ml

August 23, 2002

EMERGING PHARMA (S) PTE LTD

EMERGING PHARMA (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEMERGING PHARMA (S) PTE LTD
Licence HolderEMERGING PHARMA (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01CD01

paclitaxel

Manufacturer Information

EMERGING PHARMA (S) PTE LTD

SAMSUNG PHARMACEUTICAL IND CO LTD

Active Ingredients

PACLITAXEL

6 mg/ml

Paclitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GENEXOL INJECTION 6 mg/ml - HSA Approval | MedPath